Sources: 
Artificial intelligence (AI) and quantum computing are emerging as pivotal technologies in genomic analysis, promising significant advancements in the pursuit of
personalized medicine. While AI can assist in deciphering the extensive genetic variations across individual genomes, its full potential hinges on the ability to conduct comprehensive genome comparisons of
thousands or tens of thousands of individuals, a daunting computational task.
This need for large-scale genomic comparisons underscores the heavy computational power required to reliably navigate the complex, high-dimensional genomic landscape. The integration of
quantum computing could provide a solution, potentially reducing the runtime for medical analyses and enhancing the speed at which researchers can uncover rare-disease variants.
Despite the promise, experts caution that quantum computing "has a long way to go" before it can fully support the accelerated analysis necessary for time-sensitive clinical applications. However, if advancements are realized, these technologies could revolutionize research timelines, shortening diagnostic windows for urgent medical conditions.
Despite diligence and global efforts to connect uncommon DNA variations to human diseases, progress remains sluggish, attributed to computational limitations and gaps in scientific understanding. Overcoming these challenges presents a formidable but crucial step in advancing genomic analysis for actionable health insights.
Sources: 
AI and quantum computing hold the promise to transform genomic analysis for personalized medicine by identifying genetic variants linked to diseases, although challenges remain. Despite potential breakthroughs, practical hurdles, including computational intensity and the need for large-scale genome comparisons, persist in realizing these advancements.
